<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>modification_summary_b_049.html</title>
</head>
<body>
<p>* Expanded the company&#x27;s geographic focus to include the United Kingdom.</p>
<p>* Completed the full acquisition of U.K.-based solutions provider Kelway.</p>
<p>* Announced a future change to the operating segment reporting structure.</p>
<p>* Noted a strategic alignment with new federal government purchasing programs.</p>
<p>* Shifted the economic outlook from improving to mixed, adding interest rate risk.</p>
<p>* Reported a customer spending shift away from client devices toward integrated solutions.</p>
<p>* Added free cash flow to the list of key management metrics.</p>
<p>* Enhanced the disclosure on Adjusted EBITDA&#x27;s role in debt covenant compliance.</p>
<p>* Disclosed the adoption of a new accounting standard for deferred financing costs.</p>
<p>* Introduced organic and constant currency growth as new non-GAAP performance metrics.</p>
<p>* Attributed weaker healthcare performance to customer cost reduction amid industry consolidation.</p>
<p>* Reported gross margin improvement driven by a higher mix of services.</p>
<p>* Disclosed new acquisition and integration expenses from the Kelway transaction.</p>
<p>* Reported a significant one-time gain on the remeasurement of its Kelway investment.</p>
<p>* Added new tax disclosures regarding foreign earnings and withholding taxes.</p>
<p>* The acquisition of Kelway was completed, increasing ownership to 100%.</p>
<p>* New performance metrics for organic and constant currency growth were introduced.</p>
<p>* New non-GAAP adjustments related to the Kelway acquisition were disclosed.</p>
<p>* A new credit facility from the Kelway acquisition was added to liquidity sources.</p>
<p>* The company began actively repurchasing shares under its authorized program.</p>
<p>* Expenses related to the consolidation of office locations were newly disclosed.</p>
<p>* The quarterly cash dividend per share was increased.</p>
<p>* The explicit role of Adjusted EBITDA in debt covenants was further detailed.</p>
<p>* The normalized tax rate was lowered and new international tax items reported.</p>
<p>* A formal capital allocation strategy is now explicitly disclosed.</p>
<p>* Detailed narrative on debt extinguishments was removed from the MD&amp;A body.</p>
</body>
</html>
